Insider trades

Robert I. Blum, CEO of Cytokinetics CYTK, has filed 0 purchases and 73 sales on the open market. Over the past 12 months that comes to a net sale of $7.3M. The latest trade was on 09/28.

Robert I. Blum

President & CEO
First filing
23/01/06
Trades
190 trades
Buys / sales
0 / 73
12-month net buying
−$7.3M
Last trade
09/28

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan09/2809/287,500 sh$65.46$490,950−2.6%
Open-market sale10b5-1 plan06/1506/157,500 sh$70.46$528,450−1.9%
Open-market sale10b5-1 plan05/2705/287,500 sh$77.21$579,075−1.9%
Open-market sale10b5-1 plan05/1405/147,500 sh$77.92$584,400−1.8%
Open-market sale10b5-1 plan04/2904/297,500 sh$59.62$447,150−1.8%
Open-market sale10b5-1 plan04/1504/157,500 sh$65.38$490,350−1.8%
Open-market sale10b5-1 plan04/0104/017,500 sh$66.63$499,725−1.7%
CYTK
Open-market sale03/1703/1836,601 sh2 trades$62.15avg.$2,274,752.15−7.8%
Open-market sale03/0903/107,931 sh$60.72$481,570.32−2.0%
Open-market sale10b5-1 plan25/10/3025/10/305,000 sh$62.86$314,300−1.4%
Open-market sale10b5-1 plan25/10/1625/10/165,000 sh$60.03$300,150−1.4%
Open-market sale10b5-1 plan25/10/0125/10/015,000 sh$55.05$275,250−1.3%
Open-market sale10b5-1 plan25/09/1525/09/155,000 sh$49.77$248,850−1.3%
Open-market sale10b5-1 plan25/09/0225/09/025,000 sh$48.76$243,800−1.3%
Open-market sale10b5-1 plan25/08/1525/08/155,000 sh$38.42$192,100−1.3%
Open-market sale10b5-1 plan25/07/2925/07/315,000 sh$36.45$182,250−1.3%
Open-market sale10b5-1 plan25/07/1425/07/155,000 sh$38.15$190,750−1.3%
Open-market sale10b5-1 plan25/07/0125/07/025,000 sh$33.55$167,750−1.2%
Open-market sale10b5-1 plan25/06/1625/06/165,000 sh$33.80$169,000−1.2%
Open-market sale10b5-1 plan25/06/0225/06/025,000 sh$31.22$156,100−1.2%